Parandoush Abbasian1, Monika Foroghy2, Amir Reza Jalilian3, Amir Hakimi1, Simindokht Shirvani-Arani3. 1. Health Physics and Dosimetry Laboratory, Department of Energy Engineering and Physics, Amir Kabir University of Technology, Tehran, Iran. 2. Department of Nuclear Engineering, Science and Research Branch, Islamic Azad University, P.O. Box 14515-775, Tehran, Iran. 3. Nuclear Science Research School, Nuclear Science and Technology Research Institute, Tehran 11365-3486, Iran.
Abstract
AIM: The main purpose of this work was to develop a pharmacokinetic model for the bone pain palliation agent Samarium-153 ethylenediamine tetramethylene phosphonate ([(153)Sm]-EDTMP) in normal rats to analyze the behavior of the complex. BACKGROUND: The use of compartmental analysis allows a mathematical separation of tissues and organs to determine the concentration of activity in each fraction of interest. Biodistribution studies are expensive and difficult to carry out in humans, but such data can be obtained easily in rodents. MATERIALS AND METHODS: We have developed a physiologically based pharmacokinetic model for scaling up activity concentration in each organ versus time. The mathematical model uses physiological parameters including organ volumes, blood flow rates, and vascular permabilities; the compartments (organs) are connected anatomically. This allows the use of scale-up techniques to predict new complex distribution in humans in each organ. RESULTS: The concentration of the radiopharmaceutical in various organs was measured at different times. The temporal behavior of biodistribution of (153)Sm-EDTMP was modeled and drawn as a function of time. CONCLUSIONS: The variation of pharmaceutical concentration in all organs is described with summation of 6-10 exponential terms and it approximates our experimental data with precision better than 2%.
AIM: The main purpose of this work was to develop a pharmacokinetic model for the bone pain palliation agent Samarium-153 ethylenediamine tetramethylene phosphonate ([(153)Sm]-EDTMP) in normal rats to analyze the behavior of the complex. BACKGROUND: The use of compartmental analysis allows a mathematical separation of tissues and organs to determine the concentration of activity in each fraction of interest. Biodistribution studies are expensive and difficult to carry out in humans, but such data can be obtained easily in rodents. MATERIALS AND METHODS: We have developed a physiologically based pharmacokinetic model for scaling up activity concentration in each organ versus time. The mathematical model uses physiological parameters including organ volumes, blood flow rates, and vascular permabilities; the compartments (organs) are connected anatomically. This allows the use of scale-up techniques to predict new complex distribution in humans in each organ. RESULTS: The concentration of the radiopharmaceutical in various organs was measured at different times. The temporal behavior of biodistribution of (153)Sm-EDTMP was modeled and drawn as a function of time. CONCLUSIONS: The variation of pharmaceutical concentration in all organs is described with summation of 6-10 exponential terms and it approximates our experimental data with precision better than 2%.
Authors: J A Siegel; S R Thomas; J B Stubbs; M G Stabin; M T Hays; K F Koral; J S Robertson; R W Howell; B W Wessels; D R Fisher; D A Weber; A B Brill Journal: J Nucl Med Date: 1999-02 Impact factor: 10.057
Authors: M Tripathi; T Singhal; N Chandrasekhar; P Kumar; C Bal; P K Jhulka; G Bandopadhyaya; A Malhotra Journal: Indian J Cancer Date: 2006 Apr-Jun Impact factor: 1.224
Authors: J F Eary; C Collins; M Stabin; C Vernon; S Petersdorf; M Baker; S Hartnett; S Ferency; S J Addison; F Appelbaum Journal: J Nucl Med Date: 1993-07 Impact factor: 10.057
Authors: D P Dearnaley; R J Bayly; R P A'Hern; J Gadd; M M Zivanovic; V J Lewington Journal: Clin Oncol (R Coll Radiol) Date: 1992-03 Impact factor: 4.126